Prenatal and neonatal thyroid stimulating hormone levels and autism spectrum disorders

J Autism Dev Disord. 2015 Mar;45(3):719-30. doi: 10.1007/s10803-014-2227-2.

Abstract

Thyroid hormones are critical for normal brain development. This study examined autism spectrum disorders (ASD) and thyroid stimulating hormone (TSH) levels measured in mid-pregnancy maternal serum and infant blood after birth. Three groups of children born in Orange County, CA in 2000-2001 were identified: ASD (n = 78), developmental delay (n = 45), and general population controls (GP) (n = 149). Samples were retrieved from prenatal and newborn screening specimen archives. Adjusted logistic regression models showed inverse associations between ASD and log transformed TSH levels in maternal serum samples (ASD vs. GP: OR [95 % CI] 0.33 [0.12-0.91], Early Onset ASD vs. GP: 0.31 [0.10-0.98]). Results for thyroid levels in newborn blood samples were similar though not significant (ASD vs. GP: 0.61 [0.18-2.04]).

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Biomarkers / blood
  • Case-Control Studies
  • Child Development Disorders, Pervasive / blood*
  • Child Development Disorders, Pervasive / etiology
  • Child, Preschool
  • Developmental Disabilities / blood*
  • Developmental Disabilities / etiology
  • Dried Blood Spot Testing
  • Female
  • Humans
  • Infant, Newborn
  • Intellectual Disability / blood*
  • Intellectual Disability / etiology
  • Logistic Models
  • Male
  • Mothers*
  • Pregnancy / blood*
  • Prenatal Diagnosis*
  • Risk Assessment
  • Thyrotropin / blood*
  • Young Adult

Substances

  • Biomarkers
  • Thyrotropin